Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Unidade de Nefrologia Pediátrica do Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Sex Dev. 2022;16(1):46-54. doi: 10.1159/000517373. Epub 2021 Aug 13.
Wilms' tumor suppressor gene 1 (WT1) plays an essential role in urogenital and kidney development. Heterozygous germline pathogenic allelic variants of WT1 have been classically associated with Denys-Drash syndrome (DDS) and Frasier syndrome (FS). Usually, exonic pathogenic missense variants in the zinc finger region are the cause of DDS, whereas pathogenic variants affecting the canonic donor lysine-threonine-serine splice site in intron 9 cause FS. Phenotypic overlap between WT1 disorders has been frequently observed. New WT1 variant-associated phenotypes, such as 46,XX testicular/ovarian-testicular disorders of sex development (DSD) and primary ovarian insufficiency, have been reported. In this report, we describe the phenotypes and genotypes of 7 Brazilian patients with pathogenic WT1 variants. The molecular study involved Sanger sequencing and massively parallel targeted sequencing using a DSD-associated gene panel. Six patients (5 with a 46,XY karyotype and 1 with a 46,XX karyotype) were initially evaluated for atypical genitalia, and a 46,XY patient with normal female genitalia sought medical attention for primary amenorrhea. Germ cell tumors were identified in 2 patients, both with variants affecting alternative splicing of WT1 between exons 9 and 10. Two pathogenic missense WT1 variants were identified in two 46,XY individuals with Wilms' tumors; both patients were <1 year of age at the time of diagnosis. A novel WT1 variant, c.1453_1456 (p.Arg485Glyfs*14), was identified in a 46,XX patient with testicular DSD. Nephrotic proteinuria was diagnosed in all patients, including 3 who underwent renal transplantation after progressing to end-stage kidney disease. The expanding phenotypic spectrum associated with WT1 variants in XY and XX individuals confirms their pivotal role in gonadal and renal development as well as in tumorigenesis, emphasizing the clinical implications of these variants in genetic diagnosis.
WT1 抑癌基因 1 在泌尿生殖系统和肾脏发育中发挥重要作用。WT1 的杂合性种系致病性等位基因变异与 Denys-Drash 综合征(DDS)和 Fraser 综合征(FS)相关。通常,锌指区域的外显子致病性错义变异导致 DDS,而影响内含子 9 中经典供体赖氨酸-苏氨酸-丝氨酸剪接位点的致病性变异导致 FS。WT1 疾病之间的表型重叠经常被观察到。已经报道了 WT1 变异相关的新表型,例如 46,XX 睾丸/卵巢-睾丸性发育障碍(DSD)和原发性卵巢功能不全。在本报告中,我们描述了 7 名巴西患者的 WT1 致病性变异相关表型和基因型。分子研究包括 Sanger 测序和使用 DSD 相关基因panel 的大规模平行靶向测序。6 名患者(5 名 46,XY 核型和 1 名 46,XX 核型)最初因异常生殖器而接受评估,1 名 46,XY 患者因原发性闭经而寻求医疗关注。2 名患者均诊断为生殖细胞瘤,均存在影响 WT1 外显子 9 和 10 之间可变剪接的变异。2 名 46,XY 患有 Wilms 肿瘤的个体中发现了 2 个致病性错义 WT1 变异;诊断时患者均小于 1 岁。一名 46,XX 患者被诊断为睾丸 DSD,携带一种新型 WT1 变异,c.1453_1456(p.Arg485Glyfs*14)。所有患者均出现肾病性蛋白尿,包括 3 名在进展为终末期肾病后接受肾移植的患者。与 XY 和 XX 个体中的 WT1 变异相关的表型谱不断扩大,证实了它们在性腺和肾脏发育以及肿瘤发生中的关键作用,强调了这些变异在遗传诊断中的临床意义。